Cargando…

Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype

BACKGROUND: Epithelial ovarian tumors (EOTs) are a group of heterogeneous neoplasms. It is importance to preoperatively differentiate the histologic subtypes of EOTs. Our study aims to investigate the potential of radiomics signatures based on diffusion-weighted imaging (DWI) and apparent diffusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yi, Luo, Hong-Jian, Ren, Jialiang, Guo, Li-mei, Niu, Jinliang, Song, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762272/
https://www.ncbi.nlm.nih.gov/pubmed/36544703
http://dx.doi.org/10.3389/fonc.2022.978123
_version_ 1784852829198876672
author Xu, Yi
Luo, Hong-Jian
Ren, Jialiang
Guo, Li-mei
Niu, Jinliang
Song, Xiaoli
author_facet Xu, Yi
Luo, Hong-Jian
Ren, Jialiang
Guo, Li-mei
Niu, Jinliang
Song, Xiaoli
author_sort Xu, Yi
collection PubMed
description BACKGROUND: Epithelial ovarian tumors (EOTs) are a group of heterogeneous neoplasms. It is importance to preoperatively differentiate the histologic subtypes of EOTs. Our study aims to investigate the potential of radiomics signatures based on diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps for categorizing EOTs. METHODS: This retrospectively enrolled 146 EOTs patients [34 with borderline EOT(BEOT), 30 with type I and 82 with type II epithelial ovarian cancer (EOC)]. A total of 390 radiomics features were extracted from DWI and ADC maps. Subsequently, the LASSO algorithm was used to reduce the feature dimensions. A radiomics signature was established using multivariable logistic regression method with 3-fold cross-validation and repeated 50 times. Patients with bilateral lesions were included in the validation cohort and a heuristic selection method was established to select the tumor with maximum probability for final consideration. A nomogram incorporating the radiomics signature and clinical characteristics was also developed. Receiver operator characteristic, decision curve analysis (DCA), and net reclassification index (NRI) were applied to compare the diagnostic performance and clinical net benefit of predictive model. RESULTS: For distinguishing BEOT from EOC, the radiomics signature and nomogram showed more favorable discrimination than the clinical model (0.915 vs. 0.852 and 0.954 vs. 0.852, respectively) in the training cohort. In classifying early-stage type I and type II EOC, the radiomics signature exhibited superior diagnostic performance over the clinical model (AUC 0.905 vs. 0.735). The diagnostic efficacy of the nomogram was the same as that of the radiomics model with NRI value of -0.1591 (P = 0.7268). DCA also showed that the radiomics model and combined model had higher net benefits than the clinical model. CONCLUSION: Radiomics analysis based on DWI, and ADC maps serve as an effective quantitative approach to categorize EOTs.
format Online
Article
Text
id pubmed-9762272
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97622722022-12-20 Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype Xu, Yi Luo, Hong-Jian Ren, Jialiang Guo, Li-mei Niu, Jinliang Song, Xiaoli Front Oncol Oncology BACKGROUND: Epithelial ovarian tumors (EOTs) are a group of heterogeneous neoplasms. It is importance to preoperatively differentiate the histologic subtypes of EOTs. Our study aims to investigate the potential of radiomics signatures based on diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps for categorizing EOTs. METHODS: This retrospectively enrolled 146 EOTs patients [34 with borderline EOT(BEOT), 30 with type I and 82 with type II epithelial ovarian cancer (EOC)]. A total of 390 radiomics features were extracted from DWI and ADC maps. Subsequently, the LASSO algorithm was used to reduce the feature dimensions. A radiomics signature was established using multivariable logistic regression method with 3-fold cross-validation and repeated 50 times. Patients with bilateral lesions were included in the validation cohort and a heuristic selection method was established to select the tumor with maximum probability for final consideration. A nomogram incorporating the radiomics signature and clinical characteristics was also developed. Receiver operator characteristic, decision curve analysis (DCA), and net reclassification index (NRI) were applied to compare the diagnostic performance and clinical net benefit of predictive model. RESULTS: For distinguishing BEOT from EOC, the radiomics signature and nomogram showed more favorable discrimination than the clinical model (0.915 vs. 0.852 and 0.954 vs. 0.852, respectively) in the training cohort. In classifying early-stage type I and type II EOC, the radiomics signature exhibited superior diagnostic performance over the clinical model (AUC 0.905 vs. 0.735). The diagnostic efficacy of the nomogram was the same as that of the radiomics model with NRI value of -0.1591 (P = 0.7268). DCA also showed that the radiomics model and combined model had higher net benefits than the clinical model. CONCLUSION: Radiomics analysis based on DWI, and ADC maps serve as an effective quantitative approach to categorize EOTs. Frontiers Media S.A. 2022-12-05 /pmc/articles/PMC9762272/ /pubmed/36544703 http://dx.doi.org/10.3389/fonc.2022.978123 Text en Copyright © 2022 Xu, Luo, Ren, Guo, Niu and Song https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Xu, Yi
Luo, Hong-Jian
Ren, Jialiang
Guo, Li-mei
Niu, Jinliang
Song, Xiaoli
Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype
title Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype
title_full Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype
title_fullStr Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype
title_full_unstemmed Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype
title_short Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype
title_sort diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: assessment of histologic subtype
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762272/
https://www.ncbi.nlm.nih.gov/pubmed/36544703
http://dx.doi.org/10.3389/fonc.2022.978123
work_keys_str_mv AT xuyi diffusionweightedimagingbasedradiomicsinepithelialovariantumorsassessmentofhistologicsubtype
AT luohongjian diffusionweightedimagingbasedradiomicsinepithelialovariantumorsassessmentofhistologicsubtype
AT renjialiang diffusionweightedimagingbasedradiomicsinepithelialovariantumorsassessmentofhistologicsubtype
AT guolimei diffusionweightedimagingbasedradiomicsinepithelialovariantumorsassessmentofhistologicsubtype
AT niujinliang diffusionweightedimagingbasedradiomicsinepithelialovariantumorsassessmentofhistologicsubtype
AT songxiaoli diffusionweightedimagingbasedradiomicsinepithelialovariantumorsassessmentofhistologicsubtype